Nutraceutical Evaluation of Trigonelline's Therapeutic Potential by Targeting Bladder Cancer Stem Cells and Cancer-Associated Fibroblasts via Downregulation of TGFβ3/GLI2/YAP1 Signaling Hub
International Journal of Medical Sciences · 2025
DOI: 10.7150/ijms.107228 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Medical Sciences, 2025. Verfasst von Chien-Chang Kao und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Urology, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Alkaloids. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Urology, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
- Ph.D. Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University and Academia Sinica, Taipei 11031, Taiwan.
- Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan.
- TMU Research Center of Cancer Translational Medicine, Taipei Medical University, Taipei 11031, Taiwan.
- International PhD Program for Translational Science, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan.
- Institute of Microbiology and Immunology, National Yang-Ming Chiao Tung University, Hsinchu 30010, Taiwan.
Zitieren
APA
Kao, C. C., Shih, J. W., Huynh, H. T. L. K., Chang, C. H., Lawal, B., Iamsaard, S., Azizah, N., Ritmaleni, R., Lin, J. K., Huang, P. Y., Wu, A. T. H., & Liu, M. C. (2025). Nutraceutical Evaluation of Trigonelline's Therapeutic Potential by Targeting Bladder Cancer Stem Cells and Cancer-Associated Fibroblasts via Downregulation of TGFβ3/GLI2/YAP1 Signaling Hub. International Journal of Medical Sciences. https://doi.org/10.7150/ijms.107228
Vancouver
Kao CC, Shih JW, Huynh HTLK, Chang CH, Lawal B, Iamsaard S, et al. Nutraceutical Evaluation of Trigonelline's Therapeutic Potential by Targeting Bladder Cancer Stem Cells and Cancer-Associated Fibroblasts via Downregulation of TGFβ3/GLI2/YAP1 Signaling Hub. International Journal of Medical Sciences. 2025. doi:10.7150/ijms.107228
BibTeX
@article{Kao2025,
author = {Kao, Chien-Chang and Shih, Jing-Wen and Huynh, Huong Thi Luu Kim and Chang, Ching-Hsin and Lawal, Bashir and Iamsaard, Sitthichai and Azizah, Nur and Ritmaleni, Ritmaleni and Lin, Justin Kung-Yi and Huang, Po-Yang and Wu, Alexander T H and Liu, Ming-Che},
title = {Nutraceutical Evaluation of Trigonelline's Therapeutic Potential by Targeting Bladder Cancer Stem Cells and Cancer-Associated Fibroblasts via Downregulation of TGFβ3/GLI2/YAP1 Signaling Hub},
journal = {International Journal of Medical Sciences},
year = {2025},
doi = {10.7150/ijms.107228}
}
EUVIMED